SECTION I General Aspects of Vaccination 1 A Short History of Vaccination 2 Vaccine Immunology 3 Non-specific Effects of Vaccines 4 Correlates of Protection 5 The Vaccine Industry 6 Vaccine Manufacturing 7 Evolution of Adjuvants Across the Centuries 8 Vaccine Additives and Manufacturing Residuals in Vaccines Licensed in the United States 9 Passive Immunization SECTION II Licenced Vaccines and Vaccines in Development 10 General Immunization Practices 11 Human Adenovirus Vaccines 12 Anthrax Vaccines 13 Biodefense Vaccines, Vaccines for Emerging Infectious Diseases, and Coalition for Epidemic Preparedness Innovations (CEPI) 14 Cancer Vaccines 15 Cholera Vaccines 16 Combination Vaccines 17 Coronavirus Vaccines 18 Cytomegalovirus Vaccines 19 Dengue Vaccines 20 Vaccines Against Diarrhea Caused by Noncholera Bacteria 21 Diphtheria Toxoid 22 Ebola Vaccines 23 Nonpolio Enteroviruses 24 Epstein-Barr Virus Vaccines 25 Haemophilus Influenzae Type b Vaccines 26 Hepatitis A Vaccines 27 Hepatitis B Vaccines 28 Hepatitis C Vaccines 29 Hepatitis E Vaccines 30 Herpes Simplex Virus Vaccines 31 Human Immunodeficiency Virus Vaccines 32 Human Papillomavirus Vaccines 33 Inactivated and Recombinant Influenza Vaccines 34 Influenza Vaccine-Live 35 Japanese Encephalitis Vaccines 36 Lyme Disease Vaccines-the Journey Continues 37 Malaria Vaccines 38 Measles Vaccines 39 Meningococcal Capsular Group A, C, W, and Y Conjugate Vaccines 40 Meningococcal Vaccines Directed at Capsular Group B 41 Mumps Vaccines 42 Noninfectious Disease Vaccines 43 Norovirus 44 Parasitic Disease Vaccines 45 Pertussis Vaccines 46 Plague Vaccines 47 Pneumococcal Conjugate Vaccine and Pneumococcal Common Protein Vaccines 48 Pneumococcal Polysaccharide Vaccines 49 Poliovirus Vaccine-Inactivated 50 Poliovirus Vaccine-Live 51 Lyssaviruses and Rabies Vaccines 52 Respiratory Syncytial Virus Vaccines and Monoclonal Antibodies 53 Rotavirus Vaccines 54 Rubella Vaccines 55 Smallpox and Vaccinia 56 Staphylococcus aureus Vaccines 57 Streptococcus Group A Vaccines 58 Streptococcus Group B Vaccines 59 Tetanus Toxoid 60 Tickborne Encephalitis Vaccines 61 Tuberculosis Vaccines 62 Typhoid Fever Vaccines 63 Varicella Vaccines 64 Yellow Fever Vaccine 65 Zika Virus Vaccines 66 Zoster Vaccines SECTION III New Technologies 67 Technologies for Making New Vaccines 68 Genetic-Based Vaccine Vectors 69 Technologies to Improve Immunization SECTION IV Vaccination of Special Groups 70 Vaccination of Immunocompromised Hosts 71 Vaccines for International Travel 72 Vaccines for Healthcare Personnel 73 Vaccination of Pregnant Women SECTION V Public Health and Regulatory Issues 74 Immunization in the United States 75 Immunization in Europe 76 Immunization and Vaccine-Preventable Diseases in the Asia-Pacific Region 77 Immunization in Low- and Middle-Income Countries 78 Community Protection 79 Economic Analyses of Vaccine Policies 80 Regulation and Testing of Vaccines in the US 81 Regulation of Vaccines in Europe 82 Regulation of Vaccines in Low- and Middle-Income Countries 83 Vaccine Safety 84 Vaccine Hesitancy and Behavioral Factors Associated With Vaccine Uptake 85 Legal Issues 86 Ethics ONLINE ONLY 87 Vaccines to Prevent Mpox APPENDIX Websites and Applications for Mobile Devices With Information About Immunization Index.